POS5- PREVALENCE OF PHARMACOTHERAPY FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS IN A MANAGED CARE ENVIRONMENT
Abstract
Authors
J Hall M Nelson
J Hall M Nelson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now